The effect of anticancer therapy on anti-hepatitis B antibody titres in patients with haematological malignancies and solid tumours
Conclusion
High levels of anti-HBs may have a protective effect against the reactivation of HBV especially in patients with haematological malignancies who received immunosuppressive anticancer therapy.
Source: Journal of International Medical Research - Category: Research Authors: Yilmaz, B., Erdem, D., Teker, F., Goren, I., Yildirim, B., Kut, E., Sarikaya, D., Atay, M. H., Yucel, I. Tags: Clinical Reports Source Type: research
More News: Cancer & Oncology | Chemotherapy | Hepatitis | Hepatitis B | Hepatitis Vaccine | Research | Rituxan | Study | Vaccines